Picture of Newbury Pharmaceuticals AB logo

NEWBRY — Newbury Pharmaceuticals AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Brief: Newbury Pharmaceuticals Q2 EBITDA Loss SEK 1 Mln

April 9 (Reuters) - Newbury Pharmaceuticals AB NEWBRY.ST:

Q2 EBITDA SEK -1 MILLION

Q2 REVENUE SEK 3 MILLION

Source text: ID:nMFN8JCGWX

Further company coverage: NEWBRY.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Newbury Pharmaceuticals AB

See all news